The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Lung Surfactants Market Research Report 2024
Synopsis
It is a natural surfactant prepared from the lungs of pigs or cows, which restores breathing through trachea or injection. Mostly used for premature babies.
The global Lung Surfactants market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Lung Surfactants is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Lung Surfactants is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Lung Surfactants include Chiesi Farmaceutici, AbbVie, ONY Biotech, Lyomark Pharma, Windtree Therapeutics and Aviva Systems Biology Corporation, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Lung Surfactants, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lung Surfactants.
Report Scope
The Lung Surfactants market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Lung Surfactants market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Lung Surfactants manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Chiesi Farmaceutici
AbbVie
ONY Biotech
Lyomark Pharma
Windtree Therapeutics
Aviva Systems Biology Corporation
Segment by Type
Intratracheal
Injectable
Segment by Application
Hospital
Special Clinic
Recovery Center
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Lung Surfactants manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Lung Surfactants in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
It is a natural surfactant prepared from the lungs of pigs or cows, which restores breathing through trachea or injection. Mostly used for premature babies.
The global Lung Surfactants market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Lung Surfactants is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Lung Surfactants is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Lung Surfactants include Chiesi Farmaceutici, AbbVie, ONY Biotech, Lyomark Pharma, Windtree Therapeutics and Aviva Systems Biology Corporation, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Lung Surfactants, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lung Surfactants.
Report Scope
The Lung Surfactants market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Lung Surfactants market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Lung Surfactants manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Chiesi Farmaceutici
AbbVie
ONY Biotech
Lyomark Pharma
Windtree Therapeutics
Aviva Systems Biology Corporation
Segment by Type
Intratracheal
Injectable
Segment by Application
Hospital
Special Clinic
Recovery Center
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Lung Surfactants manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Lung Surfactants in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Lung Surfactants Market Overview
1.1 Product Overview and Scope of Lung Surfactants
1.2 Lung Surfactants Segment by Type
1.2.1 Global Lung Surfactants Market Value Comparison by Type (2024-2030)
1.2.2 Intratracheal
1.2.3 Injectable
1.3 Lung Surfactants Segment by Application
1.3.1 Global Lung Surfactants Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Special Clinic
1.3.4 Recovery Center
1.4 Global Lung Surfactants Market Size Estimates and Forecasts
1.4.1 Global Lung Surfactants Revenue 2019-2030
1.4.2 Global Lung Surfactants Sales 2019-2030
1.4.3 Global Lung Surfactants Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Lung Surfactants Market Competition by Manufacturers
2.1 Global Lung Surfactants Sales Market Share by Manufacturers (2019-2024)
2.2 Global Lung Surfactants Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Lung Surfactants Average Price by Manufacturers (2019-2024)
2.4 Global Lung Surfactants Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Lung Surfactants, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Lung Surfactants, Product Type & Application
2.7 Lung Surfactants Market Competitive Situation and Trends
2.7.1 Lung Surfactants Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Lung Surfactants Players Market Share by Revenue
2.7.3 Global Lung Surfactants Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Lung Surfactants Retrospective Market Scenario by Region
3.1 Global Lung Surfactants Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Lung Surfactants Global Lung Surfactants Sales by Region: 2019-2030
3.2.1 Global Lung Surfactants Sales by Region: 2019-2024
3.2.2 Global Lung Surfactants Sales by Region: 2025-2030
3.3 Global Lung Surfactants Global Lung Surfactants Revenue by Region: 2019-2030
3.3.1 Global Lung Surfactants Revenue by Region: 2019-2024
3.3.2 Global Lung Surfactants Revenue by Region: 2025-2030
3.4 North America Lung Surfactants Market Facts & Figures by Country
3.4.1 North America Lung Surfactants Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Lung Surfactants Sales by Country (2019-2030)
3.4.3 North America Lung Surfactants Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Lung Surfactants Market Facts & Figures by Country
3.5.1 Europe Lung Surfactants Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Lung Surfactants Sales by Country (2019-2030)
3.5.3 Europe Lung Surfactants Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Lung Surfactants Market Facts & Figures by Country
3.6.1 Asia Pacific Lung Surfactants Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Lung Surfactants Sales by Country (2019-2030)
3.6.3 Asia Pacific Lung Surfactants Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Lung Surfactants Market Facts & Figures by Country
3.7.1 Latin America Lung Surfactants Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Lung Surfactants Sales by Country (2019-2030)
3.7.3 Latin America Lung Surfactants Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Lung Surfactants Market Facts & Figures by Country
3.8.1 Middle East and Africa Lung Surfactants Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Lung Surfactants Sales by Country (2019-2030)
3.8.3 Middle East and Africa Lung Surfactants Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Lung Surfactants Sales by Type (2019-2030)
4.1.1 Global Lung Surfactants Sales by Type (2019-2024)
4.1.2 Global Lung Surfactants Sales by Type (2025-2030)
4.1.3 Global Lung Surfactants Sales Market Share by Type (2019-2030)
4.2 Global Lung Surfactants Revenue by Type (2019-2030)
4.2.1 Global Lung Surfactants Revenue by Type (2019-2024)
4.2.2 Global Lung Surfactants Revenue by Type (2025-2030)
4.2.3 Global Lung Surfactants Revenue Market Share by Type (2019-2030)
4.3 Global Lung Surfactants Price by Type (2019-2030)
5 Segment by Application
5.1 Global Lung Surfactants Sales by Application (2019-2030)
5.1.1 Global Lung Surfactants Sales by Application (2019-2024)
5.1.2 Global Lung Surfactants Sales by Application (2025-2030)
5.1.3 Global Lung Surfactants Sales Market Share by Application (2019-2030)
5.2 Global Lung Surfactants Revenue by Application (2019-2030)
5.2.1 Global Lung Surfactants Revenue by Application (2019-2024)
5.2.2 Global Lung Surfactants Revenue by Application (2025-2030)
5.2.3 Global Lung Surfactants Revenue Market Share by Application (2019-2030)
5.3 Global Lung Surfactants Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Chiesi Farmaceutici
6.1.1 Chiesi Farmaceutici Corporation Information
6.1.2 Chiesi Farmaceutici Description and Business Overview
6.1.3 Chiesi Farmaceutici Lung Surfactants Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Chiesi Farmaceutici Lung Surfactants Product Portfolio
6.1.5 Chiesi Farmaceutici Recent Developments/Updates
6.2 AbbVie
6.2.1 AbbVie Corporation Information
6.2.2 AbbVie Description and Business Overview
6.2.3 AbbVie Lung Surfactants Sales, Revenue and Gross Margin (2019-2024)
6.2.4 AbbVie Lung Surfactants Product Portfolio
6.2.5 AbbVie Recent Developments/Updates
6.3 ONY Biotech
6.3.1 ONY Biotech Corporation Information
6.3.2 ONY Biotech Description and Business Overview
6.3.3 ONY Biotech Lung Surfactants Sales, Revenue and Gross Margin (2019-2024)
6.3.4 ONY Biotech Lung Surfactants Product Portfolio
6.3.5 ONY Biotech Recent Developments/Updates
6.4 Lyomark Pharma
6.4.1 Lyomark Pharma Corporation Information
6.4.2 Lyomark Pharma Description and Business Overview
6.4.3 Lyomark Pharma Lung Surfactants Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Lyomark Pharma Lung Surfactants Product Portfolio
6.4.5 Lyomark Pharma Recent Developments/Updates
6.5 Windtree Therapeutics
6.5.1 Windtree Therapeutics Corporation Information
6.5.2 Windtree Therapeutics Description and Business Overview
6.5.3 Windtree Therapeutics Lung Surfactants Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Windtree Therapeutics Lung Surfactants Product Portfolio
6.5.5 Windtree Therapeutics Recent Developments/Updates
6.6 Aviva Systems Biology Corporation
6.6.1 Aviva Systems Biology Corporation Corporation Information
6.6.2 Aviva Systems Biology Corporation Description and Business Overview
6.6.3 Aviva Systems Biology Corporation Lung Surfactants Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Aviva Systems Biology Corporation Lung Surfactants Product Portfolio
6.6.5 Aviva Systems Biology Corporation Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Lung Surfactants Industry Chain Analysis
7.2 Lung Surfactants Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Lung Surfactants Production Mode & Process
7.4 Lung Surfactants Sales and Marketing
7.4.1 Lung Surfactants Sales Channels
7.4.2 Lung Surfactants Distributors
7.5 Lung Surfactants Customers
8 Lung Surfactants Market Dynamics
8.1 Lung Surfactants Industry Trends
8.2 Lung Surfactants Market Drivers
8.3 Lung Surfactants Market Challenges
8.4 Lung Surfactants Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Lung Surfactants Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Lung Surfactants Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Lung Surfactants Market Competitive Situation by Manufacturers in 2023
Table 4. Global Lung Surfactants Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Lung Surfactants Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Lung Surfactants Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Lung Surfactants Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Lung Surfactants Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Lung Surfactants, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Lung Surfactants, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Lung Surfactants, Product Type & Application
Table 12. Global Key Manufacturers of Lung Surfactants, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Lung Surfactants by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Surfactants as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Lung Surfactants Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Lung Surfactants Sales by Region (2019-2024) & (K Units)
Table 18. Global Lung Surfactants Sales Market Share by Region (2019-2024)
Table 19. Global Lung Surfactants Sales by Region (2025-2030) & (K Units)
Table 20. Global Lung Surfactants Sales Market Share by Region (2025-2030)
Table 21. Global Lung Surfactants Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Lung Surfactants Revenue Market Share by Region (2019-2024)
Table 23. Global Lung Surfactants Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Lung Surfactants Revenue Market Share by Region (2025-2030)
Table 25. North America Lung Surfactants Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Lung Surfactants Sales by Country (2019-2024) & (K Units)
Table 27. North America Lung Surfactants Sales by Country (2025-2030) & (K Units)
Table 28. North America Lung Surfactants Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Lung Surfactants Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Lung Surfactants Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Lung Surfactants Sales by Country (2019-2024) & (K Units)
Table 32. Europe Lung Surfactants Sales by Country (2025-2030) & (K Units)
Table 33. Europe Lung Surfactants Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Lung Surfactants Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Lung Surfactants Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Lung Surfactants Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Lung Surfactants Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Lung Surfactants Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Lung Surfactants Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Lung Surfactants Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Lung Surfactants Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Lung Surfactants Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Lung Surfactants Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Lung Surfactants Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Lung Surfactants Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Lung Surfactants Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Lung Surfactants Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Lung Surfactants Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Lung Surfactants Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Lung Surfactants Sales (K Units) by Type (2019-2024)
Table 51. Global Lung Surfactants Sales (K Units) by Type (2025-2030)
Table 52. Global Lung Surfactants Sales Market Share by Type (2019-2024)
Table 53. Global Lung Surfactants Sales Market Share by Type (2025-2030)
Table 54. Global Lung Surfactants Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Lung Surfactants Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Lung Surfactants Revenue Market Share by Type (2019-2024)
Table 57. Global Lung Surfactants Revenue Market Share by Type (2025-2030)
Table 58. Global Lung Surfactants Price (US$/Unit) by Type (2019-2024)
Table 59. Global Lung Surfactants Price (US$/Unit) by Type (2025-2030)
Table 60. Global Lung Surfactants Sales (K Units) by Application (2019-2024)
Table 61. Global Lung Surfactants Sales (K Units) by Application (2025-2030)
Table 62. Global Lung Surfactants Sales Market Share by Application (2019-2024)
Table 63. Global Lung Surfactants Sales Market Share by Application (2025-2030)
Table 64. Global Lung Surfactants Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Lung Surfactants Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Lung Surfactants Revenue Market Share by Application (2019-2024)
Table 67. Global Lung Surfactants Revenue Market Share by Application (2025-2030)
Table 68. Global Lung Surfactants Price (US$/Unit) by Application (2019-2024)
Table 69. Global Lung Surfactants Price (US$/Unit) by Application (2025-2030)
Table 70. Chiesi Farmaceutici Corporation Information
Table 71. Chiesi Farmaceutici Description and Business Overview
Table 72. Chiesi Farmaceutici Lung Surfactants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Chiesi Farmaceutici Lung Surfactants Product
Table 74. Chiesi Farmaceutici Recent Developments/Updates
Table 75. AbbVie Corporation Information
Table 76. AbbVie Description and Business Overview
Table 77. AbbVie Lung Surfactants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. AbbVie Lung Surfactants Product
Table 79. AbbVie Recent Developments/Updates
Table 80. ONY Biotech Corporation Information
Table 81. ONY Biotech Description and Business Overview
Table 82. ONY Biotech Lung Surfactants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. ONY Biotech Lung Surfactants Product
Table 84. ONY Biotech Recent Developments/Updates
Table 85. Lyomark Pharma Corporation Information
Table 86. Lyomark Pharma Description and Business Overview
Table 87. Lyomark Pharma Lung Surfactants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Lyomark Pharma Lung Surfactants Product
Table 89. Lyomark Pharma Recent Developments/Updates
Table 90. Windtree Therapeutics Corporation Information
Table 91. Windtree Therapeutics Description and Business Overview
Table 92. Windtree Therapeutics Lung Surfactants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Windtree Therapeutics Lung Surfactants Product
Table 94. Windtree Therapeutics Recent Developments/Updates
Table 95. Aviva Systems Biology Corporation Corporation Information
Table 96. Aviva Systems Biology Corporation Description and Business Overview
Table 97. Aviva Systems Biology Corporation Lung Surfactants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Aviva Systems Biology Corporation Lung Surfactants Product
Table 99. Aviva Systems Biology Corporation Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. Lung Surfactants Distributors List
Table 103. Lung Surfactants Customers List
Table 104. Lung Surfactants Market Trends
Table 105. Lung Surfactants Market Drivers
Table 106. Lung Surfactants Market Challenges
Table 107. Lung Surfactants Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Lung Surfactants
Figure 2. Global Lung Surfactants Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Lung Surfactants Market Share by Type in 2023 & 2030
Figure 4. Intratracheal Product Picture
Figure 5. Injectable Product Picture
Figure 6. Global Lung Surfactants Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Lung Surfactants Market Share by Application in 2023 & 2030
Figure 8. Hospital
Figure 9. Special Clinic
Figure 10. Recovery Center
Figure 11. Global Lung Surfactants Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Lung Surfactants Market Size (2019-2030) & (US$ Million)
Figure 13. Global Lung Surfactants Sales (2019-2030) & (K Units)
Figure 14. Global Lung Surfactants Average Price (US$/Unit) & (2019-2030)
Figure 15. Lung Surfactants Report Years Considered
Figure 16. Lung Surfactants Sales Share by Manufacturers in 2023
Figure 17. Global Lung Surfactants Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Lung Surfactants Players: Market Share by Revenue in 2023
Figure 19. Lung Surfactants Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Lung Surfactants Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Lung Surfactants Sales Market Share by Country (2019-2030)
Figure 22. North America Lung Surfactants Revenue Market Share by Country (2019-2030)
Figure 23. U.S. Lung Surfactants Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Lung Surfactants Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Lung Surfactants Sales Market Share by Country (2019-2030)
Figure 26. Europe Lung Surfactants Revenue Market Share by Country (2019-2030)
Figure 27. Germany Lung Surfactants Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Lung Surfactants Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Lung Surfactants Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Lung Surfactants Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Lung Surfactants Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Lung Surfactants Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Lung Surfactants Revenue Market Share by Region (2019-2030)
Figure 34. China Lung Surfactants Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Lung Surfactants Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Lung Surfactants Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Lung Surfactants Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Lung Surfactants Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Taiwan Lung Surfactants Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Lung Surfactants Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Lung Surfactants Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Lung Surfactants Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Philippines Lung Surfactants Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Lung Surfactants Sales Market Share by Country (2019-2030)
Figure 45. Latin America Lung Surfactants Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Lung Surfactants Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Lung Surfactants Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Lung Surfactants Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Lung Surfactants Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Lung Surfactants Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Lung Surfactants Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Lung Surfactants Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Lung Surfactants Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Lung Surfactants by Type (2019-2030)
Figure 55. Global Revenue Market Share of Lung Surfactants by Type (2019-2030)
Figure 56. Global Lung Surfactants Price (US$/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of Lung Surfactants by Application (2019-2030)
Figure 58. Global Revenue Market Share of Lung Surfactants by Application (2019-2030)
Figure 59. Global Lung Surfactants Price (US$/Unit) by Application (2019-2030)
Figure 60. Lung Surfactants Value Chain
Figure 61. Lung Surfactants Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
